Can you prescribe Augmentin (amoxicillin‑clavulanate) for a possible sexually transmitted infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Augmentin Should Not Be Prescribed for Possible STIs

Augmentin (amoxicillin-clavulanate) is not a recommended treatment for sexually transmitted infections and should not be used for this indication. The CDC STI treatment guidelines consistently recommend azithromycin or doxycycline as first-line therapy for chlamydia, and ceftriaxone-based regimens for gonorrhea—Augmentin appears in neither category 1.

Why Augmentin Is Inappropriate

Guideline-Based Recommendations

The most recent CDC guidelines establish clear first-line treatments for common STIs:

For Chlamydia:

  • Azithromycin 1 g orally as a single dose OR
  • Doxycycline 100 mg orally twice daily for 7 days 1

For Gonorrhea:

  • Ceftriaxone 125-250 mg IM (with dosing based on body weight in newer guidelines) 2
  • Historically combined with azithromycin or doxycycline for presumptive chlamydia coverage 1

For Non-Gonococcal Urethritis:

  • Same regimens as chlamydia (azithromycin or doxycycline) 3

The Evidence Gap

While limited older research suggests amoxicillin-clavulanate may have some activity against chlamydia 4 and gonorrhea 5, 6, these studies are from the 1980s-1990s and do not supersede current guideline recommendations. Notably:

  • The 1993 CDC guidelines mention amoxicillin (not Augmentin) only in the context of retesting after treatment—suggesting it as an inferior option 7
  • No subsequent CDC guidelines (1998,2006,2010) include amoxicillin-clavulanate as a recommended or alternative regimen 1, 8, 1, 8, 3
  • The FDA label for Augmentin does not list STIs as an approved indication 9

Critical Clinical Pitfalls

Using Augmentin for presumed STIs creates multiple problems:

  1. Inadequate coverage: Augmentin lacks reliable activity against the most common STI pathogens by current standards
  2. Resistance concerns: Gonorrhea has developed extensive resistance to penicillins and cephalosporins; using suboptimal therapy accelerates this
  3. Missed treatment opportunity: Patients may not return for follow-up, leaving them with persistent, untreated infection
  4. Complications risk: Untreated chlamydia and gonorrhea lead to pelvic inflammatory disease, infertility, ectopic pregnancy, and chronic pelvic pain 1, 8
  5. Ongoing transmission: Inadequate treatment allows continued spread to sexual partners

The Correct Approach

When STI is suspected but the specific pathogen is unknown:

  • Treat presumptively for both gonorrhea AND chlamydia if testing is unavailable or patient may not return 1
  • Use ceftriaxone 250 mg IM PLUS azithromycin 1 g orally (or doxycycline 100 mg twice daily for 7 days)
  • This dual therapy approach is explicitly recommended in guidelines because coinfection rates are high 1

If only chlamydia is suspected (e.g., in populations with low gonorrhea prevalence):

  • Azithromycin 1 g single dose (best for compliance concerns) OR
  • Doxycycline 100 mg twice daily for 7 days (equally effective, less expensive) 1

Partner treatment is essential: All sexual partners from the preceding 60 days should receive empiric treatment with the same regimen 3

Special Considerations

  • Pregnancy: Azithromycin is preferred for chlamydia; ceftriaxone remains appropriate for gonorrhea 7
  • Compliance concerns: Single-dose azithromycin is superior when adherence to multi-day regimens is questionable 1
  • Fluoroquinolone resistance: Avoid quinolones for gonorrhea due to widespread resistance 8

The bottom line: Stick to evidence-based, guideline-concordant therapy. Augmentin has no role in STI management in 2024.

Related Questions

What is the recommended dosage of amoxicillin‑clavulanic acid and doxycycline for an adult with pelvic Chlamydia infection?
What antibiotics are recommended for treating gonorrhea, chlamydia, and syphilis?
What are the first‑line antibiotic regimens for vaginal discharge syndrome (including bacterial vaginosis, trichomoniasis, and gonorrhea ± chlamydia) and how should treatment be adjusted in pregnancy?
What is the recommended first‑line treatment for uncomplicated genital Chlamydia trachomatis infection in non‑pregnant adults, and what alternative regimens are recommended for pregnant or lactating patients?
What is the recommended treatment for a teenage male with suspected sexually transmitted infections such as chlamydia, gonorrhea, syphilis, or genital herpes?
Which vitamin deficiency causes hemorrhagic cutaneous bullae?
What is the recommended evaluation and treatment approach for psychogenic erectile dysfunction?
What is the recommended nebulized dose of ipratropium bromide for a patient with an acute exacerbation of chronic obstructive pulmonary disease (COPD)?
How many hours should be waited before starting low‑molecular‑weight heparin (LMWH) in a postpartum woman with HELLP syndrome and a platelet count of 92 × 10⁹/L after removal of a lumbar epidural catheter?
Is it safe to take Vyvanse (lisdexamfetamine) 60 mg daily and add a 20 mg afternoon booster of Adderall (amphetamine/dextroamphetamine) as needed?
A patient’s albumin‑creatinine ratio has risen from 101 µg/mg to 294 µg/mg over the past three months while they are on ramipril 2.5 mg daily, amlodipine 5 mg daily, and semaglutide (Ozempic); how should this worsening albuminuria be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.